John Berger
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 30 | 2020 | 272 | 2.390 |
Why?
| | Heart Arrest | 18 | 2024 | 397 | 1.750 |
Why?
| | Cardiopulmonary Resuscitation | 13 | 2024 | 332 | 1.460 |
Why?
| | Cardiac Surgical Procedures | 7 | 2019 | 587 | 1.230 |
Why?
| | Critical Care | 13 | 2016 | 670 | 1.150 |
Why?
| | Critical Illness | 13 | 2021 | 852 | 0.880 |
Why?
| | Airway Extubation | 2 | 2015 | 60 | 0.820 |
Why?
| | Echocardiography | 3 | 2016 | 647 | 0.810 |
Why?
| | Heart Defects, Congenital | 9 | 2024 | 880 | 0.790 |
Why?
| | Respiratory Insufficiency | 4 | 2021 | 325 | 0.770 |
Why?
| | Infant | 50 | 2024 | 9820 | 0.740 |
Why?
| | Extracorporeal Membrane Oxygenation | 10 | 2019 | 347 | 0.740 |
Why?
| | Infant, Newborn | 37 | 2024 | 6270 | 0.720 |
Why?
| | Antihypertensive Agents | 2 | 2016 | 508 | 0.710 |
Why?
| | Child, Preschool | 47 | 2024 | 11511 | 0.660 |
Why?
| | Child | 58 | 2024 | 22390 | 0.610 |
Why?
| | Hospitals, Pediatric | 10 | 2020 | 539 | 0.600 |
Why?
| | Pulmonary Atresia | 2 | 2016 | 22 | 0.590 |
Why?
| | Heart Diseases | 5 | 2019 | 337 | 0.570 |
Why?
| | Coronary Care Units | 2 | 2016 | 23 | 0.570 |
Why?
| | Respiration, Artificial | 6 | 2022 | 689 | 0.560 |
Why?
| | Hypertension | 2 | 2016 | 1250 | 0.520 |
Why?
| | Patient Handoff | 1 | 2017 | 39 | 0.520 |
Why?
| | Hospital Mortality | 14 | 2020 | 938 | 0.510 |
Why?
| | Spectroscopy, Near-Infrared | 2 | 2016 | 66 | 0.510 |
Why?
| | Hemodynamics | 5 | 2020 | 1106 | 0.490 |
Why?
| | Models, Psychological | 1 | 2017 | 312 | 0.470 |
Why?
| | Operating Rooms | 1 | 2017 | 148 | 0.470 |
Why?
| | DiGeorge Syndrome | 1 | 2015 | 34 | 0.470 |
Why?
| | Tetralogy of Fallot | 1 | 2015 | 73 | 0.450 |
Why?
| | Patient Care Team | 3 | 2017 | 667 | 0.450 |
Why?
| | Cardiovascular Agents | 1 | 2016 | 157 | 0.430 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2015 | 117 | 0.430 |
Why?
| | Point-of-Care Systems | 1 | 2016 | 189 | 0.420 |
Why?
| | Ventilator Weaning | 2 | 2013 | 39 | 0.410 |
Why?
| | Patient Admission | 2 | 2015 | 203 | 0.410 |
Why?
| | Delivery Rooms | 1 | 2013 | 10 | 0.390 |
Why?
| | Heart Transplantation | 3 | 2024 | 714 | 0.390 |
Why?
| | Adolescent | 39 | 2024 | 22116 | 0.380 |
Why?
| | Oximetry | 1 | 2013 | 127 | 0.370 |
Why?
| | Quality Improvement | 3 | 2018 | 1241 | 0.370 |
Why?
| | Tertiary Care Centers | 4 | 2017 | 181 | 0.360 |
Why?
| | Arterial Pressure | 4 | 2024 | 132 | 0.360 |
Why?
| | Hypertension, Pulmonary | 3 | 2022 | 1939 | 0.350 |
Why?
| | Humans | 77 | 2024 | 141284 | 0.350 |
Why?
| | Postoperative Care | 1 | 2013 | 280 | 0.350 |
Why?
| | Echocardiography, Doppler | 1 | 2011 | 113 | 0.330 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 291 | 0.330 |
Why?
| | Death | 4 | 2013 | 124 | 0.330 |
Why?
| | Decision Support Techniques | 2 | 2017 | 433 | 0.320 |
Why?
| | Prospective Studies | 21 | 2020 | 7805 | 0.300 |
Why?
| | Fontan Procedure | 2 | 2024 | 182 | 0.290 |
Why?
| | Thrombosis | 3 | 2018 | 399 | 0.290 |
Why?
| | Heart Massage | 2 | 2018 | 11 | 0.280 |
Why?
| | Pulmonary Artery | 4 | 2018 | 1115 | 0.280 |
Why?
| | ROC Curve | 5 | 2017 | 594 | 0.280 |
Why?
| | Male | 46 | 2024 | 70140 | 0.270 |
Why?
| | Hypothermia, Induced | 4 | 2018 | 92 | 0.270 |
Why?
| | Female | 47 | 2024 | 75814 | 0.270 |
Why?
| | Communication | 4 | 2017 | 941 | 0.260 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2022 | 402 | 0.250 |
Why?
| | Parents | 6 | 2016 | 1439 | 0.250 |
Why?
| | District of Columbia | 2 | 2015 | 34 | 0.230 |
Why?
| | Severity of Illness Index | 9 | 2018 | 2904 | 0.230 |
Why?
| | Administration, Inhalation | 3 | 2022 | 594 | 0.230 |
Why?
| | Retrospective Studies | 15 | 2024 | 16447 | 0.210 |
Why?
| | Graft Rejection | 2 | 2024 | 545 | 0.210 |
Why?
| | Grief | 3 | 2013 | 43 | 0.190 |
Why?
| | Myocardium | 2 | 2024 | 911 | 0.190 |
Why?
| | Blood Gas Analysis | 2 | 2020 | 81 | 0.190 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2022 | 11 | 0.190 |
Why?
| | Tracheobronchomalacia | 1 | 2022 | 15 | 0.180 |
Why?
| | Nitric Oxide | 3 | 2022 | 894 | 0.180 |
Why?
| | Survival Analysis | 4 | 2017 | 1322 | 0.180 |
Why?
| | Hemorrhage | 2 | 2017 | 788 | 0.170 |
Why?
| | Blood Pressure | 4 | 2020 | 1740 | 0.170 |
Why?
| | Hydrocortisone | 2 | 2014 | 309 | 0.170 |
Why?
| | Algorithms | 3 | 2017 | 1764 | 0.170 |
Why?
| | Postoperative Complications | 3 | 2018 | 2831 | 0.170 |
Why?
| | Coma | 2 | 2018 | 36 | 0.160 |
Why?
| | Selenium | 4 | 2013 | 49 | 0.160 |
Why?
| | Bradycardia | 1 | 2020 | 52 | 0.160 |
Why?
| | Cross Infection | 3 | 2013 | 259 | 0.160 |
Why?
| | Hypercapnia | 1 | 2019 | 54 | 0.150 |
Why?
| | Brain Death | 1 | 2019 | 51 | 0.150 |
Why?
| | Pulmonary Ventilation | 1 | 2019 | 83 | 0.150 |
Why?
| | Neurocognitive Disorders | 1 | 2019 | 30 | 0.150 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2019 | 41 | 0.150 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 244 | 0.150 |
Why?
| | Immunocompromised Host | 2 | 2012 | 201 | 0.150 |
Why?
| | Treatment Outcome | 13 | 2024 | 11216 | 0.150 |
Why?
| | Length of Stay | 4 | 2018 | 1265 | 0.150 |
Why?
| | Risk Adjustment | 1 | 2019 | 81 | 0.150 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2017 | 4 | 0.140 |
Why?
| | Cardiac Catheterization | 2 | 2019 | 543 | 0.140 |
Why?
| | Logistic Models | 4 | 2019 | 2098 | 0.130 |
Why?
| | Age Factors | 4 | 2018 | 3295 | 0.130 |
Why?
| | Premature Birth | 1 | 2021 | 363 | 0.130 |
Why?
| | Cardiopulmonary Bypass | 2 | 2018 | 217 | 0.130 |
Why?
| | Zinc | 4 | 2013 | 298 | 0.130 |
Why?
| | Thromboxane B2 | 1 | 2016 | 24 | 0.130 |
Why?
| | von Willebrand Diseases | 1 | 2016 | 28 | 0.130 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 287 | 0.130 |
Why?
| | Risk Factors | 8 | 2018 | 10490 | 0.130 |
Why?
| | Intensive Care Units | 4 | 2016 | 868 | 0.130 |
Why?
| | Carbon Dioxide | 1 | 2018 | 241 | 0.120 |
Why?
| | Guideline Adherence | 2 | 2018 | 560 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1610 | 0.120 |
Why?
| | Enoxaparin | 1 | 2017 | 68 | 0.120 |
Why?
| | Dietary Supplements | 2 | 2012 | 572 | 0.120 |
Why?
| | Platelet Activation | 1 | 2016 | 94 | 0.120 |
Why?
| | Sepsis | 3 | 2013 | 627 | 0.120 |
Why?
| | Thromboembolism | 1 | 2017 | 126 | 0.120 |
Why?
| | Cardiac Output, Low | 1 | 2016 | 46 | 0.120 |
Why?
| | Phenylpropionates | 1 | 2015 | 21 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 88 | 0.120 |
Why?
| | Sildenafil Citrate | 1 | 2015 | 59 | 0.120 |
Why?
| | Risk Assessment | 4 | 2018 | 3522 | 0.120 |
Why?
| | Reproducibility of Results | 4 | 2023 | 3345 | 0.120 |
Why?
| | Pyridazines | 1 | 2015 | 56 | 0.120 |
Why?
| | Unconsciousness | 1 | 2015 | 21 | 0.110 |
Why?
| | Immune System Diseases | 1 | 2015 | 38 | 0.110 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 319 | 0.110 |
Why?
| | Standard of Care | 1 | 2016 | 77 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2018 | 278 | 0.110 |
Why?
| | Thrombelastography | 1 | 2016 | 175 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2017 | 271 | 0.110 |
Why?
| | Bereavement | 2 | 2013 | 58 | 0.110 |
Why?
| | Abdomen | 1 | 2016 | 138 | 0.110 |
Why?
| | Receptor, Melanocortin, Type 2 | 1 | 2014 | 1 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2017 | 282 | 0.110 |
Why?
| | Catheterization | 1 | 2015 | 185 | 0.110 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 332 | 0.110 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 21 | 0.110 |
Why?
| | Myocarditis | 2 | 2019 | 99 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 320 | 0.110 |
Why?
| | Analgesics, Opioid | 3 | 2013 | 1117 | 0.110 |
Why?
| | Pediatrics | 5 | 2015 | 1102 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3734 | 0.110 |
Why?
| | Stress, Physiological | 3 | 2013 | 449 | 0.110 |
Why?
| | Time Factors | 8 | 2018 | 6951 | 0.110 |
Why?
| | Whooping Cough | 2 | 2011 | 55 | 0.110 |
Why?
| | Congresses as Topic | 1 | 2015 | 223 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2015 | 197 | 0.100 |
Why?
| | Regional Blood Flow | 1 | 2016 | 497 | 0.100 |
Why?
| | Inservice Training | 1 | 2014 | 119 | 0.100 |
Why?
| | Young Adult | 6 | 2019 | 13727 | 0.100 |
Why?
| | Lactates | 1 | 2013 | 85 | 0.100 |
Why?
| | Clinical Trials Data Monitoring Committees | 1 | 2013 | 3 | 0.100 |
Why?
| | Heart Failure | 2 | 2017 | 2096 | 0.100 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2015 | 123 | 0.100 |
Why?
| | Early Termination of Clinical Trials | 1 | 2013 | 18 | 0.100 |
Why?
| | Inpatients | 1 | 2017 | 513 | 0.100 |
Why?
| | Aspirin | 1 | 2016 | 388 | 0.100 |
Why?
| | Child Development | 2 | 2017 | 496 | 0.100 |
Why?
| | Survival Rate | 5 | 2019 | 1979 | 0.100 |
Why?
| | Physicians | 2 | 2013 | 930 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 919 | 0.100 |
Why?
| | Prolactin | 1 | 2013 | 92 | 0.100 |
Why?
| | Blood Platelets | 1 | 2016 | 387 | 0.100 |
Why?
| | Research Design | 3 | 2016 | 1105 | 0.100 |
Why?
| | Professional-Family Relations | 2 | 2011 | 152 | 0.100 |
Why?
| | Research | 1 | 2016 | 434 | 0.090 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 416 | 0.090 |
Why?
| | Perioperative Care | 1 | 2014 | 228 | 0.090 |
Why?
| | United States | 11 | 2019 | 15298 | 0.090 |
Why?
| | Anticoagulants | 1 | 2017 | 724 | 0.090 |
Why?
| | Professional Role | 1 | 2013 | 164 | 0.090 |
Why?
| | Ultrafiltration | 1 | 2011 | 30 | 0.090 |
Why?
| | Fentanyl | 1 | 2013 | 123 | 0.090 |
Why?
| | Morphine | 1 | 2013 | 166 | 0.090 |
Why?
| | Sulfonamides | 1 | 2015 | 576 | 0.090 |
Why?
| | Asthma | 3 | 2012 | 1911 | 0.090 |
Why?
| | Societies, Medical | 1 | 2015 | 859 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 874 | 0.080 |
Why?
| | Cardiac Output | 1 | 2011 | 177 | 0.080 |
Why?
| | Patient Discharge | 4 | 2019 | 915 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2014 | 520 | 0.080 |
Why?
| | Multivariate Analysis | 4 | 2018 | 1505 | 0.080 |
Why?
| | Gestational Age | 1 | 2013 | 952 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1336 | 0.070 |
Why?
| | Diastole | 2 | 2019 | 141 | 0.070 |
Why?
| | Fetus | 1 | 2013 | 797 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2010 | 181 | 0.070 |
Why?
| | Metoclopramide | 3 | 2013 | 19 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2069 | 0.070 |
Why?
| | Brain | 2 | 2017 | 2857 | 0.070 |
Why?
| | Positive-Pressure Respiration | 2 | 2022 | 107 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 401 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2122 | 0.060 |
Why?
| | Glutamine | 3 | 2013 | 107 | 0.060 |
Why?
| | Cooperative Behavior | 1 | 2010 | 456 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5222 | 0.060 |
Why?
| | Lung | 2 | 2018 | 4051 | 0.060 |
Why?
| | Incidence | 3 | 2017 | 2809 | 0.060 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1546 | 0.060 |
Why?
| | Clinical Protocols | 2 | 2017 | 273 | 0.060 |
Why?
| | Cohort Studies | 5 | 2018 | 5809 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 680 | 0.060 |
Why?
| | Pregnancy | 2 | 2021 | 7035 | 0.060 |
Why?
| | Adult | 5 | 2016 | 39319 | 0.060 |
Why?
| | Glucocorticoids | 1 | 2009 | 534 | 0.060 |
Why?
| | Pain | 1 | 2010 | 779 | 0.050 |
Why?
| | Breath Holding | 1 | 2023 | 10 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2024 | 209 | 0.050 |
Why?
| | Phantoms, Imaging | 1 | 2023 | 150 | 0.050 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2022 | 104 | 0.050 |
Why?
| | Opioid-Related Disorders | 1 | 2010 | 568 | 0.050 |
Why?
| | Ventilators, Mechanical | 1 | 2022 | 62 | 0.040 |
Why?
| | Heart-Assist Devices | 2 | 2018 | 561 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1073 | 0.040 |
Why?
| | Whey Proteins | 2 | 2012 | 9 | 0.040 |
Why?
| | Milk Proteins | 2 | 2012 | 35 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2022 | 227 | 0.040 |
Why?
| | Reperfusion | 1 | 2020 | 44 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 541 | 0.040 |
Why?
| | Rocky Mountain Spotted Fever | 1 | 2019 | 2 | 0.040 |
Why?
| | Capnography | 1 | 2019 | 17 | 0.040 |
Why?
| | Pupil Disorders | 1 | 2019 | 7 | 0.040 |
Why?
| | Heart | 1 | 2023 | 616 | 0.040 |
Why?
| | Cerebral Infarction | 1 | 2019 | 49 | 0.040 |
Why?
| | Apnea | 1 | 2019 | 25 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2021 | 330 | 0.040 |
Why?
| | Systole | 1 | 2019 | 175 | 0.040 |
Why?
| | Brain Edema | 1 | 2019 | 63 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 406 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2013 | 910 | 0.040 |
Why?
| | Hypotension | 1 | 2019 | 126 | 0.040 |
Why?
| | Interviews as Topic | 2 | 2013 | 839 | 0.040 |
Why?
| | Glasgow Coma Scale | 1 | 2019 | 206 | 0.030 |
Why?
| | Tidal Volume | 1 | 2018 | 103 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2018 | 289 | 0.030 |
Why?
| | Registries | 2 | 2018 | 2205 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2018 | 144 | 0.030 |
Why?
| | Pressure | 1 | 2018 | 232 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 599 | 0.030 |
Why?
| | Shock, Septic | 1 | 2019 | 214 | 0.030 |
Why?
| | Epinephrine | 1 | 2018 | 148 | 0.030 |
Why?
| | Adolescent Development | 1 | 2017 | 89 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2929 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2017 | 164 | 0.030 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2017 | 134 | 0.030 |
Why?
| | Guidelines as Topic | 2 | 2011 | 269 | 0.030 |
Why?
| | Benchmarking | 1 | 2018 | 179 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2018 | 364 | 0.030 |
Why?
| | Collateral Circulation | 1 | 2016 | 20 | 0.030 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 246 | 0.030 |
Why?
| | von Willebrand Factor | 1 | 2016 | 84 | 0.030 |
Why?
| | Lactic Acid | 1 | 2018 | 303 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2017 | 418 | 0.030 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2016 | 45 | 0.030 |
Why?
| | Disability Evaluation | 1 | 2017 | 304 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 206 | 0.030 |
Why?
| | Body Temperature | 1 | 2017 | 224 | 0.030 |
Why?
| | Treatment Failure | 1 | 2017 | 355 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 771 | 0.030 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2014 | 11 | 0.030 |
Why?
| | Burns | 1 | 2019 | 350 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2015 | 161 | 0.030 |
Why?
| | Hospitalization | 2 | 2017 | 2264 | 0.030 |
Why?
| | Patient Simulation | 1 | 2014 | 39 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 341 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 626 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 684 | 0.030 |
Why?
| | Cardiology | 2 | 2006 | 286 | 0.030 |
Why?
| | Patient Safety | 1 | 2017 | 335 | 0.030 |
Why?
| | Medical Futility | 1 | 2013 | 28 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2018 | 1090 | 0.020 |
Why?
| | Lymphopenia | 1 | 2013 | 67 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2013 | 167 | 0.020 |
Why?
| | Area Under Curve | 1 | 2013 | 324 | 0.020 |
Why?
| | Midazolam | 1 | 2013 | 72 | 0.020 |
Why?
| | Attitude to Death | 1 | 2013 | 69 | 0.020 |
Why?
| | Status Asthmaticus | 1 | 2012 | 13 | 0.020 |
Why?
| | Anesthesia, Inhalation | 1 | 2012 | 14 | 0.020 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2012 | 35 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 328 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 717 | 0.020 |
Why?
| | Centrifugation | 1 | 2011 | 26 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2765 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 878 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3577 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 669 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2014 | 501 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2013 | 373 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4080 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 986 | 0.020 |
Why?
| | Hypnotics and Sedatives | 1 | 2013 | 215 | 0.020 |
Why?
| | Tachyphylaxis | 1 | 2010 | 5 | 0.020 |
Why?
| | Receptors, Opioid | 1 | 2010 | 23 | 0.020 |
Why?
| | Psychometrics | 1 | 2014 | 736 | 0.020 |
Why?
| | Antibiotic Prophylaxis | 1 | 2011 | 122 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 1057 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2010 | 105 | 0.020 |
Why?
| | Infection Control | 1 | 2011 | 171 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1220 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1854 | 0.020 |
Why?
| | Ethics, Research | 1 | 2009 | 29 | 0.020 |
Why?
| | Anti-Asthmatic Agents | 1 | 2012 | 273 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 306 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1820 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2010 | 129 | 0.020 |
Why?
| | Physician's Role | 1 | 2011 | 218 | 0.020 |
Why?
| | Uncertainty | 1 | 2009 | 137 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2010 | 552 | 0.020 |
Why?
| | Immune System | 1 | 2010 | 183 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1013 | 0.020 |
Why?
| | Parenteral Nutrition | 1 | 2009 | 105 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 655 | 0.020 |
Why?
| | DNA | 1 | 2014 | 1440 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 1992 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2009 | 208 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2055 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 684 | 0.020 |
Why?
| | Patient Readmission | 1 | 2012 | 698 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2013 | 680 | 0.020 |
Why?
| | Social Support | 1 | 2010 | 629 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1043 | 0.020 |
Why?
| | Neurons | 1 | 2010 | 1611 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1866 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 5653 | 0.010 |
Why?
| | Middle Aged | 1 | 2011 | 34658 | 0.000 |
Why?
|
|
Berger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|